Monday
January 20, 2020
Gangnam-gu, South Korea
Fine Dust :
The Korea Ginseng Corporation (KGC) signed a memorandum of understanding with the International Vaccine Institute to develop a vaccine adjuvant, KGC announced Friday.
LG Group Chairman Koo Kwang-mo has donated 1 billion won ($835,000) to the International Vaccine Institute (IVI), an international nonprofit organization for vaccine research and development.
U.S. biotechnology company Inovio will embark on Korea’s first clinical trials for a Covid-19 vaccine candidate, this month at earliest.
Korea JoongAng Daily Sitemap